Literature DB >> 27457221

Waitlist Outcomes of Liver Transplant Candidates Who Were Reprioritized Under Share 35.

E K H Chow1, A B Massie1, X Luo1, C E Wickliffe1, S E Gentry2, A M Cameron1, D L Segev1,3.   

Abstract

Under Share 35, deceased donor (DD) livers are offered regionally to candidates with Model for End-Stage Liver Disease (MELD) scores ≥35 before being offered locally to candidates with MELD scores <35. Using Scientific Registry of Transplant Recipients data from June 2013 to June 2015, we identified 1768 DD livers exported to regional candidates with MELD scores ≥35 who were transplanted at a median MELD score of 39 (interquartile range [IQR] 37-40) with 30-day posttransplant survival of 96%. In total, 1764 (99.8%) exports had an ABO-compatible candidate in the recovering organ procurement organization (OPO), representing 1219 unique reprioritized candidates who would have had priority over the regional candidate under pre-Share 35 allocation. Reprioritized candidates had a median waitlist MELD score of 31 (IQR 27-34) when the liver was exported. Overall, 291 (24%) reprioritized candidates had a comparable MELD score (within 3 points of the regional recipient), and 209 (72%) were eventually transplanted in 11 days (IQR 3-38 days) using a local (50%), regional (50%) or national (<1%) liver; 60 (21%) died, 13 (4.5%) remained on the waitlist and nine (3.1%) were removed for other reasons. Of those eventually transplanted, MELD score did not increase in 57%; it increased by 1-3 points in 37% and by ≥4 points in 5.7% after the export. In three cases, OPOs exchanged regional exports within a 24-h window. The majority of comparable reprioritized candidates were not disadvantaged; however, 21% died after an export. © Copyright 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  epidemiology; health services and outcomes research; liver transplantation/hepatology; organ allocation; organ procurement and allocation

Mesh:

Year:  2016        PMID: 27457221      PMCID: PMC5433796          DOI: 10.1111/ajt.13980

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  15 in total

1.  The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality.

Authors:  D E Schaubel; C S Sima; N P Goodrich; S Feng; R M Merion
Journal:  Am J Transplant       Date:  2008-01-07       Impact factor: 8.086

2.  Share 35: a liver in time saves lives?

Authors:  S Feng; J O'Grady
Journal:  Am J Transplant       Date:  2015-03       Impact factor: 8.086

Review 3.  Minimising cold ischaemic time is essential in cardiac death donor-associated liver transplantation.

Authors:  Seth J Karp; Scott Johnson; Amy Evenson; Michael P Curry; Diarmuid Manning; Raza Malik; Gerond Lake-Bakaar; Michelle Lai; Douglas Hanto
Journal:  HPB (Oxford)       Date:  2011-04-04       Impact factor: 3.647

4.  Early changes in liver distribution following implementation of Share 35.

Authors:  A B Massie; E K H Chow; C E Wickliffe; X Luo; S E Gentry; D C Mulligan; D L Segev
Journal:  Am J Transplant       Date:  2015-03       Impact factor: 8.086

Review 5.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

6.  The impact of proposed changes in liver allocation policy on cold ischemia times and organ transportation costs.

Authors:  D A DuBay; P A MacLennan; R D Reed; M Fouad; M Martin; C B Meeks; G Taylor; M L Kilgore; M Tankersley; S H Gray; J A White; D E Eckhoff; J E Locke
Journal:  Am J Transplant       Date:  2015-02       Impact factor: 8.086

7.  The survival benefit of liver transplantation.

Authors:  Robert M Merion; Douglas E Schaubel; Dawn M Dykstra; Richard B Freeman; Friedrich K Port; Robert A Wolfe
Journal:  Am J Transplant       Date:  2005-02       Impact factor: 8.086

8.  The Impact of Redistricting Proposals on Health Care Expenditures for Liver Transplant Candidates and Recipients.

Authors:  S E Gentry; E K H Chow; N Dzebisashvili; M A Schnitzler; K L Lentine; C E Wickliffe; E Shteyn; J Pyke; A Israni; B Kasiske; D L Segev; D A Axelrod
Journal:  Am J Transplant       Date:  2016-01-18       Impact factor: 8.086

9.  Results of the first year of the new liver allocation plan.

Authors:  Richard B Freeman; Russell H Wiesner; Erick Edwards; Ann Harper; Robert Merion; Robert Wolfe
Journal:  Liver Transpl       Date:  2004-01       Impact factor: 5.799

10.  MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients.

Authors:  Walter K Kremers; Marrije van IJperen; W Ray Kim; Richard B Freeman; Ann M Harper; Patrick S Kamath; Russell H Wiesner
Journal:  Hepatology       Date:  2004-03       Impact factor: 17.425

View more
  5 in total

1.  Same policy, different impact: Center-level effects of share 35 liver allocation.

Authors:  Douglas R Murken; Allison W Peng; David D Aufhauser; Peter L Abt; David S Goldberg; Matthew H Levine
Journal:  Liver Transpl       Date:  2017-06       Impact factor: 5.799

2.  Share 35 changes in center-level liver acceptance practices.

Authors:  David S Goldberg; Matthew Levine; Seth Karp; Richard Gilroy; Peter L Abt
Journal:  Liver Transpl       Date:  2017-05       Impact factor: 5.799

3.  Improved posttransplant mortality after share 35 for liver transplantation.

Authors:  Allison J Kwong; Aparna Goel; Ajitha Mannalithara; W Ray Kim
Journal:  Hepatology       Date:  2017-11-13       Impact factor: 17.425

4.  Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (≤15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data.

Authors:  K Atiemo; A Skaro; H Maddur; L Zhao; S Montag; L VanWagner; S Goel; A Kho; B Ho; R Kang; J L Holl; M M Abecassis; J Levitsky; D P Ladner
Journal:  Am J Transplant       Date:  2017-04-04       Impact factor: 8.086

5.  Live Donor Liver Transplantation in the United States: Impact of Share 35 on Live Donor Utilization.

Authors:  Hillary J Braun; Jennifer L Dodge; Joshua D Grab; Marisa E Schwab; Iris H Liu; Alexa C Glencer; Peter G Stock; Ryutaro Hirose; John P Roberts; Nancy L Ascher
Journal:  Transplantation       Date:  2021-04-01       Impact factor: 5.385

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.